Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
Strategies and innovations related to how clinical professionals are utilizing technology internal and external to their organizations to advance clinical trials. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
One of the largest institutional review boards in North America, IRB Services independently reviews, monitors and provides oversight of biomedical and behavioral research involving humans, working with many of the largest pharmaceutical and clinical research organizations (CROs), including many of the world’s most respected and recognized brands. IRB Services will be the first central institutional review board to license Intralinks VIA to facilitate the transfer of sensitive documents that are required during the approval process that every large pharmaceutical company (sponsor) or CRO must go through. This approval process happens during all phases of research in a clinical trial’s lifecycle and is essential to the commencement of a new or ongoing project.
“More and more clients have been requesting secure portals to help with the exchange of regulatory documents required during the clinical trial process,” said Simon A. Corman, director, Business Operations at IRB Services. “Our team is excited to use Intralinks VIA to facilitate this process. We looked at many collaborative solutions, but only Intralinks provides the security and ease-of-use we need. Further, as the first central IRB to implement the Intralinks VIA solution, we will be able to leverage the existing widespread Intralinks user base to maximize efficiencies and further solidify our position as a market leader. Utilizing a collaboration platform that we can trust with sensitive information around clinical trials on a global scale will help bolster our services in the eyes of our clients and accelerate the clinical trial process, which is always a plus.”
Intralinks provides breakthrough collaboration solutions that give demanding professionals the freedom to work confidently beyond traditional boundaries. Intralinks VIA is an elegantly simple enterprise collaboration solution that makes it easy for anyone to sync, share and UNshare™ files, work efficiently on group projects, and manage content wherever it goes – all with robust security and strong control capabilities. Used by over 99 percent of the global Fortune 1000, Intralinks’ solutions go beyond just file sharing to ensure that productive work gets done, while protecting that work wherever it goes.
“IRB Services works with virtually all of the big pharmaceutical companies, CROs and research sites, and adding Intralinks VIA will only make IRB Services more competitive,” said Douglas Gordon, senior vice president, product marketing at Intralinks. “As a market leader in ethics review services, we are proud IRB Services selected Intralinks to support its collaboration needs.”